Mochi Health
Provider Profile Name: Mochi Health
Website: joinmochi.com
Founded: 2022
Incorporated: Delaware; principal office San Francisco, CA
Provider Type: Telehealth — Virtual Only, Obesity Medicine Specialty
Operating Details
- Fully virtual — online intake forms, mandatory video consultation with provider, home delivery
- LegitScript certified
- Available in all 50 US states and Washington, D.C.
- Board-certified providers across multiple specialties, including Obstetrics and Gynecology, Bariatric Surgery, Internal Medicine, Pediatrics, Family Medicine, Endocrinology, Pediatric Endocrinology, and Cardiothoracic Surgery
- Registered dietitians included in the care team
- Insurance support for brand-name medications included
- No insurance required for compounded options; HSA/FSA eligible
- No asynchronous-only prescribing — video visit required before prescription
Approach: Unlike many telehealth clinics that rely on general nurse practitioners or PAs, Mochi Health is founded and run by board-certified healthcare providers, ensuring evidence-based care. The platform’s clinical model centers on ongoing, relationship-based care: monthly video visits with physicians or nurse practitioners, plus registered dietitian support for nutrition and lifestyle guidance, a combination that positions Mochi closer to a traditional obesity medicine clinic than to the medication-access-first platforms that dominate this review series.
About the Company
Mochi Health was founded in 2022 and incorporated in Delaware, operating nationwide with a principal office in San Francisco, California, connecting patients with board-certified doctors and dietitians who develop personalized, evidence-based weight management plans, offering care for both adults and children with or without insurance.
Mochi Health is one of the most visible telehealth companies in the compounded GLP-1 space, with a massive Facebook group of over 140,000 members and a constant presence on social media, much of this growth fueled by a “give $40, get $40” referral program that made their coupon codes ubiquitous.
Spring 2025 Pharmacy Crisis
Mochi experienced a significant operational disruption in the spring of 2025, which is essential context for prospective patients. In March 2025, Mochi’s primary pharmacy partner, Aequita Pharmacy, received a limited stop-service order from the Washington State Department of Health, forcing Mochi to scramble to switch thousands of patients to new pharmacies, including Empower and Red Rock. This, along with an Eli Lilly lawsuit filed during the same timeframe, resulted in 30-plus-day shipping delays and a confirmed lack of customer communication through April and May 2025.
As of late June 2025, Mochi appeared to be on a clear path to recovery. After speaking with the company and observing recent customer feedback, including a significant upward trend in their Trustpilot score, independent reviewers concluded that Mochi had stabilized its pharmacy operations and service levels. Patients who enrolled during the disruption period had a materially different experience than those joining after recovery, and the crisis is a relevant data point when evaluating the platform’s operational reliability.
GLP-1 Offerings and Weight Loss Services
Mochi offers one of the most comprehensive medication menus in this review series, spanning compounded GLP-1s, brand-name GLP-1s, and non-GLP-1 weight management options:
Compounded GLP-1s:
- Compounded semaglutide: $99/month at all doses (0.22mg weekly to 2.67mg weekly), shipping included
- Compounded tirzepatide: $199/month at all doses (2.2mg weekly to 16.6mg weekly), shipping included
Brand-Name GLP-1s (with insurance support):
- Wegovy and Ozempic (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda and Victoza (liraglutide), Trulicity (dulaglutide)
- Mochi specializes in helping patients use insurance for brand-name GLP-1 medications, with providers assisting with prior authorizations to help reduce out-of-pocket costs
Non-GLP-1 Weight Management Options:
- Metformin, Topiramate (Topamax), Bupropion, Naltrexone (including low-dose naltrexone), Orlistat (Xenical/Alli)
Supportive Care:
- Ondansetron/Zofran for nausea management when appropriate; NAD+, B12, Vitamin D, and other wellness supplements
Clinical Support:
- Monthly video visits with a board-certified provider
- Registered dietitian access for nutrition guidance
- 24/7 messaging support
- Pediatric care available alongside adult services
Pricing — and What Reviewers Say
Mochi separates its pricing into two components, membership and medication, which is a source of both value and confusion:
Membership: $79/month, covers all visits, messaging, and care coordination
Medication (compounded):
- Compounded semaglutide: $99/month at all doses, flat-rate regardless of titration level
- Compounded tirzepatide: $199/month at all doses, flat-rate regardless of titration level
- Shipping is included in the medication price
All-in compounded pricing:
- Semaglutide: $178/month total ($79 membership + $99 medication)
- Tirzepatide: $278/month total ($79 membership + $199 medication)
The flat-dose pricing across all titration levels is a standout feature in this review series. Most platforms charge more at higher doses, Mochi charges the same whether a patient is on a starter dose or a maximum maintenance dose, eliminating the cost escalation problem that frustrates patients on dose-escalating platforms.
What reviewers say about pricing: While the split fee structure, separating membership and medication costs, can be confusing, the combined price often positions Mochi as a low-cost provider, which has clearly resonated with a large audience. The membership fee charged before a patient knows whether they qualify is a frequently cited complaint. Multiple reviewers describe being charged the $79 membership fee before completing the eligibility assessment and learning whether they qualify for GLP-1 medications or what dosage they would receive.
Reviews from Trustpilot and Google
Mochi Health has 15,531 Trustpilot reviews at the time of writing, the largest independent review pool in this entire review series.
What patients praise:
- Provider quality is the dominant positive theme; reviewers consistently describe board-certified physicians and nurse practitioners as knowledgeable, patient-centered, and genuinely engaged with weight loss goals, rather than processing patients quickly
- Registered dietitian access alongside physician visits is noted as a clinical differentiator
- Medication logistics are praised for speed when operating normally, but some patients report receiving tirzepatide within three days of joining
- Phone support connected reviewers with live representatives in under 10 minutes in independent testing, a notable contrast to many competitors
Common complaints:
- Refund policy complaints: patients report being unable to cancel orders once sent to the pharmacy, even before the medication has been shipped, a policy that some describe as inconsistent with the website’s stated terms
- Dosage management opacity: Some reviewers report that the platform does not clearly communicate how or when doses are increased, resulting in patients remaining on starter doses for extended periods without weight loss progress, while continuing to be billed
- The pharmacy crisis of spring 2025 generated a significant volume of negative reviews during that period, though the trend has since reversed
- The membership fee charged pre-qualification is a recurring friction point among new patients
Compounding Pharmacies Used
Following its pharmacy crisis in spring 2025, Mochi transitioned from primary partner Aequita Pharmacy to Empower and Red Rock pharmacies as its main fulfillment partners. Both Empower and Red Rock are established names in the compounded GLP-1 space. Specific pharmacy partners are not prominently disclosed in the patient-facing product pages; patients should ask which pharmacy will fulfill their prescription and confirm its state licensure and 503A/503B designation before their first order.
Note: Mochi Health’s combination of flat-dose pricing, mandatory monthly video visits with board-certified providers, registered dietitian access, and one of the largest independent review pools in this series (15,531 Trustpilot reviews) positions it as one of the more clinically substantive compounded GLP-1 platforms reviewed. The spring 2025 pharmacy crisis, triggered by a stop-service order against partner Aequita Pharmacy, resulted in 30-plus day shipping delays and significant patient communication failures, though operations appeared stabilized by mid-2025. The pre-qualification membership fee charge and refund policy around pharmacy-stage cancellations are the platform’s most consistent consumer friction points. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.





